Cardiac Leaflet Enhancer (CARLEN)

CARLEN is a novel native leaflet augmenting implant that is deployed onto the mitral or tricuspid valve, using a transfemoral delivery catheter. The augmented native leaflet increases the surface of coaptation for the valve and eliminates regurgitation.

In few weeks, the CARLEN implant is engulfed in an endothelialized layer of tissue, providing a focally enhanced native leaflet that suits the patients valve geometry, addressing a large patient population.

Procedure

CARLEN builds upon the existing skillsets of the interventional cardiologist in grasping moving leaflets, and simplifies it further with a single leaflet grasp and no risk of creating mitral stenosis in any anatomy

Supported by